Propranolol inhibits cell viability and expression of the pro-tumorigenic proteins Akt, NF-ĸB, and VEGF in oral squamous cell carcinoma
- 17 February 2022
- journal article
- research article
- Published by Elsevier in Archives of Oral Biology
- Vol. 136, 105383
Abstract
No abstract availableKeywords
Funding Information
- Fundação de Amparo à Pesquisa do Estado de São Paulo (2016/00051-2, 2016/03965-2, 2016/24685-3, 2016/25255-0, 2017/18650-2)
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
This publication has 51 references indexed in Scilit:
- The functions and regulation of the PTEN tumour suppressorNature Reviews Molecular Cell Biology, 2012
- Overlooking Evolution: A Systematic Analysis of Cancer Relapse and Therapeutic Resistance ResearchPLOS ONE, 2011
- Oral complications of targeted cancer therapies: A narrative literature reviewOral Oncology, 2011
- Improved structure, function and compatibility for CellProfiler: modular high-throughput image analysis softwareBioinformatics, 2011
- β-Adrenergic receptors (β-AR) regulate VEGF and IL-6 production by divergent pathways in high β-AR-expressing breast cancer cell linesBreast Cancer Research and Treatment, 2011
- Effects of propranolol in combination with radiation on apoptosis and survival of gastric cancer cells in vitroRadiation Oncology, 2010
- Expression of β2‐adrenergic receptor in oral squamous cell carcinomaJournal of Oral Pathology & Medicine, 2009
- Inhibition of Pancreatic Cancer Cell Proliferation by Propranolol Occurs Through Apoptosis InductionPancreas, 2009
- Chemotherapeutic stress selectively activates NF-κB-dependent AKT and VEGF expression in liver cancer-derived endothelial cellsAmerican Journal of Physiology-Cell Physiology, 2007
- Norepinephrine Up-regulates the Expression of Vascular Endothelial Growth Factor, Matrix Metalloproteinase (MMP)-2, and MMP-9 in Nasopharyngeal Carcinoma Tumor CellsCancer Research, 2006